Literature DB >> 3505712

Hormonal and metabolic mechanisms in the development of cerebral pseudoatrophy in eating disorders.

J C Krieg1, C Lauer, K M Pirke.   

Abstract

Cranial computed tomography (CT) examinations performed on patients with schizophrenia, affective disorders or on patients with anorexia and bulimia nervosa revealed morphological brain alterations. In patients with eating disorders these structural changes were characterized by enlarged ventricles and sulci. Malnourishment-induced hormonal and metabolic disturbances may be responsible for this morphological brain alteration which, due to its reversibility after clinical remission, is frequently called 'pseudoatrophy'. As patients with alcohol dependency also display a cerebral pseudoatrophy, the search for similarities between alcoholics and patients with eating disorders may help to elucidate some of the pathogenetic factors which cause the CT findings in patients with different psychiatric or psychosomatic disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3505712     DOI: 10.1159/000288050

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  3 in total

Review 1.  Is anorexia nervosa a neuropsychological disease?

Authors:  C M Braun; M J Chouinard
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

2.  Impact of speed and magnitude of weight loss on the development of brain trophic changes in adolescents with anorexia nervosa: a case control study.

Authors:  Monica Bomba; Anna Riva; Federica Veggo; Marco Grimaldi; Sabrina Morzenti; Francesca Neri; Renata Nacinovich
Journal:  Ital J Pediatr       Date:  2013-02-19       Impact factor: 2.638

3.  Global and regional brain volumes normalization in weight-recovered adolescents with anorexia nervosa: preliminary findings of a longitudinal voxel-based morphometry study.

Authors:  Monica Bomba; Anna Riva; Sabrina Morzenti; Marco Grimaldi; Francesca Neri; Renata Nacinovich
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-09       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.